IGC Pharma, Inc. financial statements
IGC Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 1.27M | 10-KT |
| Net income | −USD 7.12M | 10-KT |
| Cash and equivalents | USD 405K | 10-KT |
| Total debt | USD 137K | 10-KT |
IGC Pharma, Inc. financials on 6ix · IGC Pharma, Inc. on 6ix